Disease Severity and Viral Codetection in Acute Lower Respiratory Tract Infection

Maria Katherine Sierra-Echeverri1, Ofelia Maria Perez-Lopera1, Claudia Beltran-Arroyave1,2

  • 1From the Department of Pediatrics, University of Antioquia.

Insights

Viral coinfections in children hospitalized with pneumonia are not linked to worse outcomes overall. However, in infants under one year, detecting multiple viruses is associated with more severe disease.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Virology
  • Clinical Epidemiology

Background:

  • The impact of multiple viral detections (coinfections) on respiratory infection severity in children is not well understood.
  • Investigating coinfections is crucial for understanding disease progression and outcomes in pediatric respiratory illnesses.

Purpose of the Study:

  • To determine the association between viral coinfections and disease severity in children under five hospitalized with suspected viral pneumonia.
  • To identify risk factors for severe outcomes in pediatric viral pneumonia.

Main Methods:

  • A case-control study was conducted with children hospitalized between September 2019 and June 2022.
  • Cases met severity criteria (complicated pneumonia, ICU admission, ventilation, death), while controls did not.
  • Multiplex polymerase chain reaction (PCR) was used for viral detection, and multivariate logistic regression analyzed associations.

Main Results:

  • Of 561 patients, 39.8% had viral coinfections. Overall, coinfection was not significantly associated with increased severity (adjusted OR = 1.4).
  • Younger age (<1 year) and prior bronchiolitis were independently associated with greater severity.
  • In infants under one year, viral coinfection was significantly associated with increased severity (adjusted OR = 2.7).

Conclusions:

  • Viral coinfections are not a significant predictor of severity in all children hospitalized with suspected viral pneumonia.
  • However, coinfection is a critical factor associated with more severe disease specifically in infants under one year of age.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
5.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
564
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K